Pharma and realty sectors delivered robust performance this quarter, propelled by strong demand and improved operational efficiencies, much like the previous period. In contrast, energy and infrastructure struggled with income growth challenges. Although revenue expansion decelerated, falling below the average year-over-year increase of the last four quarters, profitability stayed resilient, with margin expansion compensating for slower revenue gains overall performance.